Insight

Apple's stock hits a record high as Jim Cramer tells investors to hold, citing strong iPhone demand, services growth and market momentum.

President Trump is threatening to call in federal troops to San Francisco as evidence mounts that the city is undergoing a post-pandemic resurgence.

After White House AI and crypto czar David Sacks went after Anthropic last week, OpenAI investor Reid Hoffman came to the company's defense.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Gen X business owners are at the peak of their careers, so why are they the least optimistic among Main Street entrepreneurs? It's their age breeding anxiety.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

The announcement marks Anthropic's first formal launch within the life sciences sector

More important than a brief AWS outage is whether Amazon can reaccelerate cloud growth and use its earnings report later this month to shake off concerns that it’s an AI laggard.

The short-term setup could be promising for AMD’s stock, according to Bernstein. But delivering over a longer period gets more complicated.

Working for (or with) a control freak "can push anyone to the brink," says executive coach Melody Wilding.

The Economist ranked 100 of the major U.S. cities by affordability for people who want to live alone.

Selling Rivian’s expensive electric trucks and SUVs may get more difficult now that key tax credits have expired.

Wall Street was poised to add to Friday's rally.

It’s a prime time to pick stocks right now, says Morgan Stanley, they have some ideas.

Authenticity is overrated, according to psychologist Tomas Chamorro-Premuzic — learning these social skills will boost your career.

'Mad Money' host Jim Cramer says long-term investing, not quick profits from trading, will help you get to a secure retirement.

The iPhone maker’s shares tend to rise in the last 3 months of the year, says Evercore

An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.

Investors are climbing a “wall of worry,” when it comes to all-important U.S. assets. That shouldn’t deter them, says Indosuez Wealth Management’s chief strategist.

As they prepare to meet in 10 days on interest rates, Federal Reserve officials are very divided over a key question: How worried they ought to be about the U.S. labor market.